Back |
home / stock / rxdx / rxdx message board
Subject | By | Source | When |
---|---|---|---|
Current Major Investors | RealGenius | investorshub | 03/29/2014 5:04:47 PM |
Current holdings of management | RealGenius | investorshub | 03/29/2014 4:58:31 PM |
Outstanding common shares; 13.9M | RealGenius | investorshub | 03/29/2014 4:56:22 PM |
Relevant History | RealGenius | investorshub | 03/29/2014 4:53:32 PM |
Relevant History | RealGenius | investorshub | 03/29/2014 4:51:55 PM |
Relevant History | RealGenius | investorshub | 03/29/2014 4:47:41 PM |
Stock Tracker: Latest Ignyta Inc. (RXDX) Headlines Ignyta Announces 2013 Company Highlights and Full | Stock_Tracker | investorshangout | 03/11/2014 10:16:50 AM |
chartguy89: RXDX 8.90 Stock Charts $RXDX 1 Month Chart | chartguy89 | investorshangout | 03/09/2014 7:57:26 PM |
chartguy89: RXDX Stock Charts Last: -0.25 Saturday, March 1, 2014 at 11:34:42 AM $RXDX 1 Mon | chartguy89 | investorshangout | 03/01/2014 4:34:54 PM |
Can't buy :-/ | grinchstyle | investorshub | 01/04/2014 3:18:33 PM |
News, Short Squeeze, Breakout and More Instantly...
Prometheus Biosciences Inc. Company Name:
RXDX Stock Symbol:
NASDAQ Market:
Prometheus Biosciences Inc. Website:
NEW YORK, NY / ACCESSWIRE / May 25, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Prometheus Biosciences, Inc. (NASDAQ:RXDX...
SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutics for the treatment of immune-mediated disease...